- Home
- BPOP vs RVTY Comparison
BPOP vs RVTY Comparison
Compare BPOP & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BPOP | RVTY |
|---|---|---|
| Founded | 1893 | 1937 |
| Country | United States | United States |
| Employees | 9427 | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9B | 9.7B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | BPOP | RVTY |
|---|---|---|
| Price | $149.42 | $101.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 16 |
| Target Price | ★ $160.18 | $109.67 |
| AVG Volume (30 Days) | 457.8K | ★ 1.2M |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.03% | 0.34% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.07 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $12.86 | $6.37 |
| Revenue Next Year | $5.79 | $5.10 |
| P/E Ratio | ★ $11.87 | $47.49 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $100.54 | $81.22 |
| 52 Week High | $152.95 | $118.30 |
Technical Indicators
Market Signals| Indicator | BPOP | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 58.93 | 67.59 |
| Support Level | $141.29 | $82.88 |
| Resistance Level | $152.95 | $103.04 |
| Average True Range (ATR) | 3.14 | 4.33 |
| MACD | -0.41 | 1.56 |
| Stochastic Oscillator | 48.36 | 97.72 |
Price Performance
Historical ComparisonAbout BPOP Popular Inc.
Popular Inc, based in Puerto Rico, is a financial holding company with four main subsidiaries: Banco Popular de Puerto Rico, a bank in Puerto Rico in terms of assets; Banco Popular North America, its banking operation in the continental United States; Evertec, a data processor; and Popular Financial Holdings, a diversified financial services company. The Corporation's reportable segments consist of Banco Popular de Puerto Rico and Popular U.S.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.